Published in Lasers Med Sci on June 21, 2011
The disinfecting efficacy of root canals with laser photodynamic therapy. J Lasers Med Sci (2014) 0.86
Photodynamic therapy in root canals contaminated with Enterococcus faecalis using curcumin as photosensitizer. Lasers Med Sci (2014) 0.78
Laser Application in Dentistry: Irradiation Effects of Nd:YAG 1064 nm and Diode 810 nm and 980 nm in Infected Root Canals-A Literature Overview. Biomed Res Int (2016) 0.77
Determination of the effect of Nd:YAG laser irradiation through dentinal tubules on several oral pathogens. Lasers Med Sci (2012) 0.77
Effect of gaseous ozone on Enterococcus faecalis biofilm-an in vitro study. Clin Oral Investig (2015) 0.77
Clinical Approach of High Technology Techniques for Control and Elimination of Endodontic Microbiota. J Lasers Med Sci (2015) 0.75
In Vitro-Activity of Er:YAG Laser in Comparison with other Treatment Modalities on Biofilm Ablation from Implant and Tooth Surfaces. PLoS One (2017) 0.75
The Antibacterial Effect of Additional Photodynamic Therapy in Failed Endodontically Treated Teeth: A Pilot Study. J Lasers Med Sci (2016) 0.75
1064 Nd:YAG laser for the treatment of chronic paronychia: a pilot study. Lasers Med Sci (2013) 0.75
Bactericidal effect of erbium YAG laser on periodontopathic bacteria. Lasers Surg Med (1996) 1.46
Redefining the persistent infection in root canals: possible role of biofilm communities. J Endod (2007) 1.12
Light and electron microscopic studies of root canal flora and periapical lesions. J Endod (1987) 1.11
Nosocomial enterococci: resistance to heat and sodium hypochlorite. J Hosp Infect (1995) 1.09
Bactericidal effect of Nd:YAG laser irradiation on some endodontic pathogens ex vivo. Int Endod J (2006) 0.98
Effectiveness of different laser systems to kill Enterococcus faecalis in aqueous suspension and in an infected tooth model. Int Endod J (2009) 0.94
Bactericidal effect of the Nd:YAG laser in in vitro root canals. J Clin Laser Med Surg (1996) 0.92
Study of the direct bactericidal effect of Nd:YAG and diode laser parameters used in endodontics on pigmented and nonpigmented bacteria. Lasers Med Sci (2010) 0.90
Nd:YAG laser irradiation in root canal disinfection. Endod Dent Traumatol (1995) 0.88
Decontamination efficacy of erbium:yttrium-aluminium-garnet and diode laser light on oral Candida albicans isolates of a 5-day in vitro biofilm model. Lasers Med Sci (2008) 0.87
Bactericidal effects of 2.94 microns Er:YAG-laser radiation in dental root canals. J Endod (1999) 0.86
Root surface temperature increase during Er:YAG laser irradiation of root canals. J Endod (2002) 0.86
The bactericidal effect of Nd:YAG, Ho:YAG, and Er:YAG laser irradiation in the root canal: an in vitro comparison. J Clin Laser Med Surg (1999) 0.85
Evaluation of the antibacterial effects of intracanal Nd:YAG laser irradiation. J Endod (1994) 0.85
Comparative evaluation of the antibacterial effects of intracanal Nd:YAG laser irradiation: an in vitro study. J Endod (1995) 0.83
The Er:YAG laser in endodontics: results of an in vitro study. Lasers Surg Med (2002) 0.81
Antibacterial effects of pulsed Nd:YAG laser radiation at different energy settings in root canals. J Endod (2002) 0.81
Bactericidal action of high-power Nd:YAG laser light on Escherichia coli in saline suspension. J Appl Microbiol (2000) 0.81
Bactericidal effect of pulsed 1,064 nm Nd:YAG laser light on Staphylococcus epidermidis is of photothermal origin: an in vitro study. Lasers Surg Med (2000) 0.81
Performance assessment of novel side firing flexible optical fibers for dental applications. Lasers Surg Med (2009) 0.80
Comparative evaluation of antibacterial effects of Nd:YAG laser irradiation in root canals and dentinal tubules. J Endod (2000) 0.79
Inactivation of bacteria and yeasts on agar surfaces with high power Nd:YAG laser light. Lett Appl Microbiol (1996) 0.78
Bacteriologic evaluation of the effect of Nd:YAG laser irradiation in experimental infected root canals. J Endod (2002) 0.78
Effects of Er:YAG laser irradiation on biofilm-forming bacteria associated with endodontic pathogens in vitro. J Endod (2008) 0.78
Mechanism of high-power NIR laser bacteria inactivation. J Biophotonics (2010) 0.75
DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol (2007) 12.76
Opinion: Re-evaluating prokaryotic species. Nat Rev Microbiol (2005) 7.19
Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods (2007) 2.92
Taxonomy of the genus Cupriavidus: a tale of lost and found. Int J Syst Evol Microbiol (2004) 2.80
Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol (2003) 2.49
PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol (2004) 2.31
Effect of radiation dose on the prevalence of apical periodontitis--a dosimetric analysis. Clin Oral Investig (2012) 1.98
An epidemic Burkholderia cepacia complex strain identified in soil. Lancet (2002) 1.88
Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol (2002) 1.87
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol (2002) 1.86
Diversity and occurrence of Burkholderia spp. in the natural environment. FEMS Microbiol Rev (2008) 1.77
Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol (2003) 1.74
Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int J Syst Evol Microbiol (2004) 1.58
Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol (2005) 1.55
Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium. J Antimicrob Chemother (2008) 1.48
Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother (2011) 1.46
In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods (2010) 1.46
Burkholderia fungorum septicemia. Emerg Infect Dis (2005) 1.37
Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol (2006) 1.37
Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms. J Microbiol Methods (2005) 1.35
Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J Med Microbiol (2002) 1.33
In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother (2009) 1.30
Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol (2007) 1.19
Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR. BMC Microbiol (2008) 1.18
Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol (2002) 1.16
The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans. Mol Microbiol (2012) 1.10
Role of PvdQ in Pseudomonas aeruginosa virulence under iron-limiting conditions. Microbiology (2009) 1.09
What can be learned from genotyping of fungi? Med Mycol (2010) 1.07
Burkholderia mimosarum sp. nov., isolated from root nodules of Mimosa spp. from Taiwan and South America. Int J Syst Evol Microbiol (2006) 1.07
Arcobacter thereius sp. nov., isolated from pigs and ducks. Int J Syst Evol Microbiol (2009) 1.06
Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob Agents Chemother (2011) 1.05
Fungicidal activity of miconazole against Candida spp. biofilms. J Antimicrob Chemother (2010) 1.03
Colonization of voice prostheses by albicans and non-albicans Candida species. Laryngoscope (2002) 1.03
Assessment of microbial diversity in biofilms recovered from endotracheal tubes using culture dependent and independent approaches. PLoS One (2012) 1.02
Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite. BMC Genomics (2010) 1.01
Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One (2013) 1.01
Arcobacter cibarius sp. nov., isolated from broiler carcasses. Int J Syst Evol Microbiol (2005) 1.01
Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol (2010) 0.99
Classification of Centers for Disease Control Group Eugonic Fermenter (EF)-4a and EF-4b as Neisseria animaloris sp. nov. and Neisseria zoodegmatis sp. nov., respectively. Int J Syst Evol Microbiol (2006) 0.99
In vitro inhibition of Streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones. Antimicrob Agents Chemother (2007) 0.96
Enumeration of airborne bacteria and fungi using solid phase cytometry. J Microbiol Methods (2007) 0.95
Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery. Biomaterials (2011) 0.94
The 285 kDa Bap/RTX hybrid cell surface protein (SO4317) of Shewanella oneidensis MR-1 is a key mediator of biofilm formation. Res Microbiol (2009) 0.94
Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol (2003) 0.93
Use of quorum sensing inhibitors to interfere with biofilm formation and development in Burkholderia multivorans and Burkholderia cenocepacia. Res Microbiol (2008) 0.93
Polyphasic characterisation of Burkholderia cepacia-like isolates leading to the emended description of Burkholderia pyrrocinia. Syst Appl Microbiol (2004) 0.92
Towards a better understanding of the adhesion mechanism of resin-modified glass-ionomers by bonding to differently prepared dentin. J Dent (2010) 0.92
Enterococcus hermanniensis sp. nov., from modified-atmosphere-packaged broiler meat and canine tonsils. Int J Syst Evol Microbiol (2004) 0.92
Membrane rafts are involved in intracellular miconazole accumulation in yeast cells. J Biol Chem (2009) 0.92
Quorum sensing inhibitors: how strong is the evidence? Trends Microbiol (2013) 0.92
Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp. PLoS One (2011) 0.91
Developing an international Pseudomonas aeruginosa reference panel. Microbiologyopen (2013) 0.91
Rapid detection of single cell bacteria as a novel approach in food microbiology. J AOAC Int (2002) 0.90
Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives. Int J Antimicrob Agents (2011) 0.88
Capillary flow porometry to assess the seal provided by root-end filling materials in a standardized and reproducible way. J Endod (2006) 0.88
A quorum sensing-disrupting brominated thiophenone with a promising therapeutic potential to treat luminescent vibriosis. PLoS One (2012) 0.87
AI-2 quorum-sensing inhibitors affect the starvation response and reduce virulence in several Vibrio species, most likely by interfering with LuxPQ. Microbiology (2009) 0.87
Development of a real-time NASBA assay for the detection of Campylobacter jejuni cells. J Microbiol Methods (2006) 0.87
Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions. Mycopathologia (2008) 0.87
Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Res Microbiol (2010) 0.87
Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy. Nanomedicine (Lond) (2012) 0.86
[Critical analysis of leakage studies in endodontics]. Rev Belge Med Dent (1984) (2005) 0.86
A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria. FEMS Microbiol Lett (2005) 0.86
Lactobacillus oligofermentans sp. nov., associated with spoilage of modified-atmosphere-packaged poultry products. Appl Environ Microbiol (2005) 0.86
Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms. Pathog Dis (2014) 0.86
Involvement of toxin-antitoxin modules in Burkholderia cenocepacia biofilm persistence. Pathog Dis (2014) 0.86
Efficacy of laser-based irrigant activation methods in removing debris from simulated root canal irregularities. Lasers Med Sci (2013) 0.86
Genomewide screening for genes involved in biofilm formation and miconazole susceptibility in Saccharomyces cerevisiae. FEMS Yeast Res (2013) 0.85
Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds. Phytomedicine (2012) 0.85
The presence of antibiotic-resistant nosocomial pathogens in endotracheal tube biofilms and corresponding surveillance cultures. Pathog Dis (2013) 0.84
Synthesis and evaluation of thiazolidinedione and dioxazaborocane analogues as inhibitors of AI-2 quorum sensing in Vibrio harveyi. Bioorg Med Chem (2012) 0.84
Evaluation of a new high-throughput method for identifying quorum quenching bacteria. Sci Rep (2013) 0.84
Activity of disinfectants against multispecies biofilms formed by Staphylococcus aureus, Candida albicans and Pseudomonas aeruginosa. Biofouling (2014) 0.84
Vancomycin release from poly(D,L-lactic acid) spray-coated hydroxyapatite fibers. Eur J Pharm Biopharm (2010) 0.83
Surgical root restoration after external inflammatory root resorption: A case report. J Endod (2006) 0.83
Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen (2009) 0.83
Isolation and identification of quorum quenching bacteria from environmental samples. J Microbiol Methods (2011) 0.82